News
Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.
The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.
14h
GlobalData on MSNFDA approves GSK’s prefilled syringe presentation of ShingrixAdministering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.
While herbs like ashwagandha and turmeric are now widely recognised, ayurveda encompasses a much broader range of therapeutic ...
A bill that would have criminalized folks with sexually transmitted diseases would have been bad for people who need ...
It’s time we stop creating work that holds up a mirror to what’s broken and start imagining creative solutions that inspire a ...
KATIE Radford has rushed her nine-month-old baby to hospital and shared a very important reminder to all parents. Just days ...
The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.
In this week’s edition of The Prototype, we look at a new company building automated construction equipment, a potential new class of virus-fighting compounds and more.
3h
Everyday Health on MSNA New Treatment for Late-Stage Melanoma Uses the Power of the HerpesvirusA new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to existing therapies.
US FDA approves GSK’s Shingrix in a prefilled syringe presentation for prevention of shingles: London, UK Friday, July 18, 2025, 09:00 Hrs [IST] GSK plc announced that the US Fo ...
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results